MetaCap

Kailera Therapeutics (KLRA) News

NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.02-0.56 (-4.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KLRA news summary

We found 5 recent headlines mentioning Kailera Therapeutics (KLRA): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, KLRA is down 4.84% at $11.02. The most recent story, "Canaccord Genuity Initiates Coverage of Kailera Therapeutics with Buy Rating", was published by Nasdaq on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Kailera Therapeutics headlines

Stocks mentioned alongside KLRA

Compare KLRA